Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2018

19.05.2018 | Maternal-Fetal Medicine

Association between unexplained thickened nuchal translucency and adverse pregnancy outcomes

verfasst von: Santee Tiyatha, Sirinart Sirilert, Ratanaporn Sekararithi, Theera Tongsong

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine the association between unexplained increased nuchal translucency (INT) and adverse pregnancy outcomes.

Patients and methods

The prospective database of our fetal down screening project was accessed to retrieve the records with NT measurement and complete follow-up. Pregnancies with pre-existing medical diseases, fetal chromosomal or structural abnormalities were excluded. The selected pregnancies were classified into the INT groups (> 95th percentile), the normal (< 95th percentile) group.

Results

Of 6026 available for analysis (INT:277; and normal: 5749), the abortion rate was significantly higher in the INT group, 18/277 (6.5%) versus 55/5749 (1.0%); p < 0.001. After excluding 73 cases ending-up with abortion, a total of 5953 women were analyzed for final pregnancy outcomes, including 260 (4.4%), and 5693 (95.6%) in the study group (INT), and the control group (normal NT), respectively. The rates of pre-eclampsia (7.3 vs. 4.1%; p: 0.018), preterm birth (12.7 vs. 8.4%; p: 0.023), fetal growth restriction (11.5 vs. 7.6%; p: 0.032), and low birth weight (16.5 vs. 10.0%; p: 0.002) were slightly, but significantly higher in the study group.

Conclusions

INT in the first trimester is associated with significantly increased risk of abortion, fetal growth restriction, preterm birth, low birth weight and pre-eclampsia.
Literatur
1.
Zurück zum Zitat Shakoor S, Dileep D, Tirmizi S, Rashid S, Amin Y, Munim S (2016) Increased nuchal translucency and adverse pregnancy outcomes. J Matern Fetal Neonatal Med 30:1–4 Shakoor S, Dileep D, Tirmizi S, Rashid S, Amin Y, Munim S (2016) Increased nuchal translucency and adverse pregnancy outcomes. J Matern Fetal Neonatal Med 30:1–4
2.
Zurück zum Zitat Bilardo CM, Timmerman E, Pajkrt E, van Maarle M (2010) Increased nuchal translucency in euploid fetuses–what should we be telling the parents? Prenat Diagn 30:93–102CrossRef Bilardo CM, Timmerman E, Pajkrt E, van Maarle M (2010) Increased nuchal translucency in euploid fetuses–what should we be telling the parents? Prenat Diagn 30:93–102CrossRef
3.
Zurück zum Zitat Pajkrt E, Mol BW, Bleker OP, Bilardo CM (1999) Pregnancy outcome and nuchal translucency measurements in fetuses with a normal karyotype. PrenatDiagn 19:1104–1108 Pajkrt E, Mol BW, Bleker OP, Bilardo CM (1999) Pregnancy outcome and nuchal translucency measurements in fetuses with a normal karyotype. PrenatDiagn 19:1104–1108
4.
Zurück zum Zitat Michailidis GD, Economides DL (2001) Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 17:102–105CrossRef Michailidis GD, Economides DL (2001) Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 17:102–105CrossRef
5.
Zurück zum Zitat Westin M, Saltvedt S, Almstrom H, Grunewald C, Valentin L (2007) By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population. Ultrasound Obstet Gynecol 29:150–158CrossRef Westin M, Saltvedt S, Almstrom H, Grunewald C, Valentin L (2007) By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population. Ultrasound Obstet Gynecol 29:150–158CrossRef
6.
Zurück zum Zitat Ayras O, Tikkanen M, Eronen M, Paavonen J, Stefanovic V (2013) Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution. Prenat Diagn 33:856–862CrossRef Ayras O, Tikkanen M, Eronen M, Paavonen J, Stefanovic V (2013) Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution. Prenat Diagn 33:856–862CrossRef
7.
Zurück zum Zitat Tahmasebpour A, Rafiee NB, Ghaffari S, Jamal A (2012) Increased nuchal translucency and pregnancy outcome. Iran J Public Health 41:92–97PubMedPubMedCentral Tahmasebpour A, Rafiee NB, Ghaffari S, Jamal A (2012) Increased nuchal translucency and pregnancy outcome. Iran J Public Health 41:92–97PubMedPubMedCentral
8.
Zurück zum Zitat Mula R, Gonce A, Bennasar M, Arigita M, Meler E, Nadal A et al (2012) Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age. Ultrasound Obstet Gynecol 39:34–41CrossRef Mula R, Gonce A, Bennasar M, Arigita M, Meler E, Nadal A et al (2012) Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age. Ultrasound Obstet Gynecol 39:34–41CrossRef
9.
Zurück zum Zitat Piazze J, Anceschi MM, Cerekja A, La Torre R, Pala A, Papa A et al (2007) Nuchal translucency as a predictor of adverse pregnancy outcome. Int J Gynaecol Obstet 98:5–9CrossRef Piazze J, Anceschi MM, Cerekja A, La Torre R, Pala A, Papa A et al (2007) Nuchal translucency as a predictor of adverse pregnancy outcome. Int J Gynaecol Obstet 98:5–9CrossRef
10.
Zurück zum Zitat Sheizaf B, Sheiner E, Fink M, Hershkovitz R, Mazor M, Wiznitzer A (2009) A significant linear association exists between nuchal translucency thickness and adverse perinatal outcome in euploid fetuses. J Matern Fetal Neonatal Med 22:479–484CrossRef Sheizaf B, Sheiner E, Fink M, Hershkovitz R, Mazor M, Wiznitzer A (2009) A significant linear association exists between nuchal translucency thickness and adverse perinatal outcome in euploid fetuses. J Matern Fetal Neonatal Med 22:479–484CrossRef
11.
Zurück zum Zitat Hourrier S, Salomon LJ, Dreux S, Muller F (2010) Screening for adverse pregnancy outcome at early gestational age. Clin Chim Acta 411:1547–1552CrossRef Hourrier S, Salomon LJ, Dreux S, Muller F (2010) Screening for adverse pregnancy outcome at early gestational age. Clin Chim Acta 411:1547–1552CrossRef
13.
Zurück zum Zitat Tongsong T, Simaraks S, Sirivatanapa P, Sudasna J, Wanapirak C, Kunavikatikul C et al (1993) Study of intrauterine growth from birthweight at Maharaj Nakhon Chiang Mai Hospital. J Med Assoc Thai 76:482–486PubMed Tongsong T, Simaraks S, Sirivatanapa P, Sudasna J, Wanapirak C, Kunavikatikul C et al (1993) Study of intrauterine growth from birthweight at Maharaj Nakhon Chiang Mai Hospital. J Med Assoc Thai 76:482–486PubMed
14.
Zurück zum Zitat Haak MC, van Vugt JM (2003) Pathophysiology of increased nuchal translucency: a review of the literature. HumReprodUpdate 9:175–184 Haak MC, van Vugt JM (2003) Pathophysiology of increased nuchal translucency: a review of the literature. HumReprodUpdate 9:175–184
15.
Zurück zum Zitat Ayras O, Eronen M, Tikkanen M, Rahkola-Soisalo P, Paavonen J, Stefanovic V (2016) Long-term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening. Acta Obstet Gynecol Scand 95:541–546CrossRef Ayras O, Eronen M, Tikkanen M, Rahkola-Soisalo P, Paavonen J, Stefanovic V (2016) Long-term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening. Acta Obstet Gynecol Scand 95:541–546CrossRef
Metadaten
Titel
Association between unexplained thickened nuchal translucency and adverse pregnancy outcomes
verfasst von
Santee Tiyatha
Sirinart Sirilert
Ratanaporn Sekararithi
Theera Tongsong
Publikationsdatum
19.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2018
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-018-4790-9

Weitere Artikel der Ausgabe 1/2018

Archives of Gynecology and Obstetrics 1/2018 Zur Ausgabe

Gynecologic Endocrinology and Reproductive Medicine

Beta endorphin in serum and follicular fluid of PCOS- and non-PCOS women

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.